In the BioHarmony Drug Report Database

"Preview" Icon

Mesoridazine

Serentil (mesoridazine) is a small molecule pharmaceutical. Mesoridazine was first approved as Serentil on 1982-01-01. It is used to treat alcoholism, psychotic disorders, and schizophrenia in the USA. It is known to target 5-hydroxytryptamine receptor 2C, D(3) dopamine receptor, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 1A, D(1A) dopamine receptor, and D(2) dopamine receptor.

 

Trade Name

 

Serentil
 

Common Name

 

mesoridazine
 

ChEMBL ID

 

CHEMBL1088
 

Indication

 

alcoholism, psychotic disorders, schizophrenia
 

Drug Class

 

Typical antipsychotic

Image (chem structure or protein)

Mesoridazine structure rendering